129 related articles for article (PubMed ID: 10992318)
1. Deep venous thrombosis and consecutive pulmonary embolism as the first sign of an ovarian cancer: MR angiography using an intravascular contrast agent (CLARISCAN).
Sandstede JJ; Krause U; Pabst T; Hoffmann V; Braun H; Kenn W; Hahn D
J Magn Reson Imaging; 2000 Sep; 12(3):497-500. PubMed ID: 10992318
[TBL] [Abstract][Full Text] [Related]
2. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
Larsson EM; Sundén P; Olsson CG; Debatin J; Duerinckx AJ; Baum R; Hahn D; Ebner F
AJR Am J Roentgenol; 2003 Jan; 180(1):227-32. PubMed ID: 12490510
[TBL] [Abstract][Full Text] [Related]
3. Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease.
Klein C; Schalla S; Schnackenburg B; Bornstedt A; Hoffmann V; Fleck E; Nagel E
J Magn Reson Imaging; 2003 Jun; 17(6):656-62. PubMed ID: 12766894
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).
Bremerich J; Roberts TP; Wendland MF; Wyttenbach R; Arheden H; Reddy GP; Shafaghi N; Higgins CB; Saeed M
J Magn Reson Imaging; 2000 Jun; 11(6):622-8. PubMed ID: 10862061
[TBL] [Abstract][Full Text] [Related]
5. MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience.
Hoffmann U; Loewe C; Bernhard C; Weber M; Cejna M; Herold CJ; Schima W
J Magn Reson Imaging; 2002 Apr; 15(4):429-37. PubMed ID: 11948832
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hemorrhage: imaging with a new magnetic resonance blood pool agent in conjunction with breathheld three-dimensional magnetic resonance angiography.
Weishaupt D; Hilfiker PR; Schmidt M; Debatin JF
Cardiovasc Intervent Radiol; 1999; 22(4):321-5. PubMed ID: 10415223
[TBL] [Abstract][Full Text] [Related]
7. Value of a blood pool contrast agent in MR venography of the lower extremities and pelvis: preliminary results in 12 patients.
Aschauer M; Deutschmann HA; Stollberger R; Hausegger KA; Obernosterer A; Schöllnast H; Ebner F
Magn Reson Med; 2003 Nov; 50(5):993-1002. PubMed ID: 14587010
[TBL] [Abstract][Full Text] [Related]
8. High-resolution magnetic resonance coronary angiography of the entire heart using a new blood-pool agent, NC100150 injection: comparison with invasive x-ray angiography in pigs.
Johansson LO; Nolan MM; Taniuchi M; Fischer SE; Wickline SA; Lorenz CH
J Cardiovasc Magn Reson; 1999; 1(2):139-43. PubMed ID: 11550346
[TBL] [Abstract][Full Text] [Related]
9. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
10. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
11. Use of a blood-pool contrast agent for MR-guided vascular procedures: feasibility of ultrasmall superparamagnetic iron oxide particles.
Wacker FK; Wendt M; Ebert W; Hillenbrandt C; Wolf KJ; Lewin JS
Acad Radiol; 2002 Nov; 9(11):1251-4. PubMed ID: 12449357
[TBL] [Abstract][Full Text] [Related]
12. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
Klein C; Nagel E; Schnackenburg B; Bornstedt A; Schalla S; Hoffmann V; Lehning A; Fleck E
MAGMA; 2000 Nov; 11(1-2):65-7. PubMed ID: 11186991
[No Abstract] [Full Text] [Related]
13. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
[TBL] [Abstract][Full Text] [Related]
14. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism.
Kanne JP; Lalani TA
Circulation; 2004 Mar; 109(12 Suppl 1):I15-21. PubMed ID: 15051664
[TBL] [Abstract][Full Text] [Related]
15. Influence of blood-pool contrast media on MR imaging and flow measurements in the presence of pulmonary arterial stents in swine.
Kuehne T; Saeed M; Moore P; Gleason K; Reddy G; Teitel D; Higgins CB
Radiology; 2002 May; 223(2):439-45. PubMed ID: 11997550
[TBL] [Abstract][Full Text] [Related]
16. Initial experience with the intravascular contrast agent NC100150-injection (Clariscan) for breath-hold and navigator-gated magnetic resonance coronary artery imaging.
Bunce NH; Keegan J; Gatehouse PD; Moon JC; Firmin DN; Hoffmann V; Pennell DJ
J Magn Reson Imaging; 2002 Aug; 16(2):217-23. PubMed ID: 12203771
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced magnetic resonance angiography in the coronary and peripheral arteries.
Saeed M; Wendland MF; Engelbrecht M; Sakuma H; Higgins CB
Acad Radiol; 1998 Apr; 5 Suppl 1():S108-12. PubMed ID: 9561057
[No Abstract] [Full Text] [Related]
18. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer.
Rydland J; BjØrnerud A; Haugen O; Torheim G; Torres C; Kvistad KA; Haraldseth O
Acta Radiol; 2003 May; 44(3):275-83. PubMed ID: 12751998
[TBL] [Abstract][Full Text] [Related]
19. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography.
Taylor AM; Panting JR; Keegan J; Gatehouse PD; Amin D; Jhooti P; Yang GZ; McGill S; Burman ED; Francis JM; Firmin DN; Pennell DJ
J Magn Reson Imaging; 1999 Feb; 9(2):220-7. PubMed ID: 10077017
[TBL] [Abstract][Full Text] [Related]
20. Combined CT venography and pulmonary angiography in suspected thromboembolic disease: diagnostic accuracy for deep venous evaluation.
Loud PA; Katz DS; Klippenstein DL; Shah RD; Grossman ZD
AJR Am J Roentgenol; 2000 Jan; 174(1):61-5. PubMed ID: 10628455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
